newsfilter
← Latest News
GlobeNewswire·

Serina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizer

Provides access to Serina POZ polymer technology for potential use in lipid nanoparticle (LNP) formulations HUNTSVILLE, AL, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (Serina), a privately held,